Dynavax Technologies | Resultat Før Skatt

Pre Tax Profit Endring Dato
AbbVie USD 1.76B 4.24B 2024-03
Adma Biologics USD 18.4M 15.84M 2024-03
Amgen USD -68000000 3.09B 2024-03
AstraZeneca USD 2.8B 385M 2024-03
Biogen USD 464.8M 336.9M 2024-03
BioMarin Pharmaceutical USD 105.55M 72.22M 2024-03
Bristol-Myers Squibb USD -11516000000 15.59B 2024-03
Dynavax Technologies USD -11497000 12.49M 2024-03
Gilead Sciences USD -4486000000 7.08B 2024-03
Glaxosmithkline USD 1.36B 581.39M 2024-03
Merck USD 5.67B 6.14B 2024-03
Neurocrine Biosciences USD 34.5M 163.7M 2024-03
Novartis USD 3.13B 606M 2024-03
Pfizer USD 3.42B 4.67B 2024-03
Regeneron Pharmaceuticals USD 700.7M 698.9M 2024-03
Roche Holding CHF 10.33B 1.48B 2023-06
Sarepta Therapeutics USD 41.45M 74.62M 2024-03
TG Therapeutics USD -10678000 3.35M 2024-03
Vertex Pharmaceuticals USD 1.28B 31.7M 2024-03



Dynavax Technologies Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.